Gene test may unlock better cancer treatments for Hard-to-Treat tumors
NCT ID NCT06958224
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looks at whether doing broad gene testing early, instead of later, can help find more effective treatments for people with advanced liver, breast, or pancreatic cancers. About 360 adults with poor-prognosis cancers will be randomly assigned to early or standard gene testing. The goal is to see if early testing leads to more patients actually starting a treatment matched to their tumor's genetic profile.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.